Products Affected - Description

• • Cromolyn sodium oral solution, Micro Labs, 100 mg/5 mL, 5 mL ampule, 96 count, NDC 42571-0132-52
  • Cromolyn sodium oral solution, Rising Pharmaceuticals, 100 mg/5 mL, 5 mL ampule, 96 count, NDC 16571-0600-96
  • Cromolyn sodium oral solution, Ritedose, 100 mg/5 mL, 5 mL ampule, 96 count, NDC 76204-0025-96
  • Cromolyn sodium oral solution, Wallace Pharmaceuticals, 100 mg/5 mL, 5 mL ampule, 96 count, NDC 51525-0470-09 - discontinued
  • Cromolyn sodium oral solution, Woodward, 100 mg/5 mL, 5 mL ampule, 96 count, NDC 69784-0200-96

Reason for the Shortage

• • Micro Labs did not provide a reason for the shortage.
  • Mylan (Viatris) / Wallace has Gastrocrom oral solution available.
  • Rising has cromolyn on shortage due to increased demand.
  • Ritedose recalled one lot of cromolyn oral solution in July 2023 due to manufacturing issues.
  • Woodward did not provide a reason for the shortage.

Available Products

• • Gastrocrom oral solution, Mylan (Viatris), 100 mg/5 mL, 5 mL ampule, 96 count, NDC 00037-0678-96

• • Micro Labs has cromolyn 100 mg/5 mL oral solution on allocation.
  • Rising has cromolyn 100 mg/5 mL oral solution on back order and the company cannot estimate a release date.
  • Ritedose has cromolyn 100 mg/5 mL oral solution on back order and the company cannot estimate a release date.
  • Woodward has cromolyn 100 mg/5 mL oral solution on allocation.